Our annual survey highlights startups taking on gene therapy, adoptive immune cell therapy, gene editing, and drugs targeting RNA modifications and the unfolded protein response. Ken Garber, Esther Landhuis, Melanie Senior, Cormac Sheridan and Laura DeFrancesco report.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zinn, E. et al. Cell Rep. 12, 1056–1068 (2015).
Suzuki, J. et al. Sci. Rep. 7, 45524 (2017).
Pan, B. et al. Nat. Biotechnol. 35, 264–272 (2017).
Shearer, A. E. & Smith, R. J. Otolaryngol. Head Neck Surg. 153, 175–182 (2015).
Pan, B. et al. Neuron 99, 736–753.e6 (2018).
Jones, D. Nat. Biotechnol. 36, 1128–1129 (2018).
Cho, J. H., Collins, J. J. & Wong, W. W. Cell 173, 1426–1438.e11 (2018).
Klichinsky, M. et al. in Proceedings of the American Association for Cancer Research Annual Meeting 2017 Vol. 77, 4575 (2017), https://doi.org/10.1158/1538-7445.AM2017-4575
Ritchie, D. et al. Cancer Immunol. Immunother. 56, 155–163 (2007).
Ellebrecht, C. T. et al. Science 353, 179–184 (2016).
Liou, H. C., Boothby, M. R. & Glimcher, L. H. Science 242, 69–71 (1988).
Cubillos-Ruiz, J. et al. Cell 161, 1527–1538 (2015).
Song, M. et al. Nature 562, 423–428 (2018).
Chen, X. et al. Nature 508, 103–107 (2014).
Perry, R. P., Kelley, D. E., Friderici, K. & Rottman, F. Cell 4, 387–394 (1975).
Meyer, K. D. et al. Cell 149, 1635–1646 (2012).
Dominissini, D. et al. Nature 485, 201–206 (2012).
Geula, S. et al. Science 347, 1002–1006 (2015).
Vu, L. P. et al. Nat. Med. 23, 1369–1376 (2017).
Barbieri, I. et al. Nature 552, 126–131 (2017).
Lyko, F. Nat. Rev. Genet. 19, 81–92 (2018).
Li, Z. et al. Cancer Cell 31, 127–141 (2017).
Zhang, S. et al. Cancer Cell 31, 591–606.e6 (2017).
Zhang, C. et al. Proc. Natl Acad. Sci. USA 113, E2047–E2056 (2016).
Dominissini, D. et al. Nature 530, 441–446 (2016).
Safra, M. et al. Nature 551, 251–255 (2017).
Li, X. et al. Mol. Cell 68, 993–1005 (2017).
Carlson, D. F. et al. Nat. Biotechnol. 34, 479–481 (2016).
Lampreht Tratar, U., Horvat, S. & Cemazar, M. Front. Oncol. 8, 268 (2018).
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Nature 533, 420–424 (2016).
Gaudelli, N. M. et al. Nature 551, 464–471 (2017).
Kim, Y. B. et al. Nat. Biotechnol. 35, 371–376 (2017).
Hu, J. H. et al. Nature 556, 57–63 (2018).
Huang, T.P. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-019-0134-y (2019).
Zuo, E. et al. Science 364, 289–292 (2019).
Jin, S. et al. Science 364, 292–295 (2019).
Grünewald, J. et al. Nature https://doi.org/10.1038/s41586-019-1161-z (2019).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K., Landhuis, E., Sheridan, C. et al. Nature Biotechnology’s academic spinouts of 2018. Nat Biotechnol 37, 601–612 (2019). https://doi.org/10.1038/s41587-019-0139-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0139-6
